ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
Archives of Disease in Childhood 1987;62:1102-1106; doi:10.1136/adc.62.11.1102
Copyright © 1987 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie.

In a prospective study (Cytotoxic Drug Study II), 18 children with steroid dependent nephrotic syndrome and steroid toxicity were treated with cyclophosphamide (2 mg/kg body weight/day) for 12 weeks in combination with reducing doses of prednisone (group A). This group was compared retrospectively with 18 children with steroid dependent nephrotic syndrome, studied as part of the Cytotoxic Drug Study I, and who had received cyclophosphamide for eight weeks (group B). There were no differences between the groups in age at the onset of the nephrotic syndrome, age at entry into the study, and duration of the nephrotic syndrome before entry into the study. The number of relapses during the six months before the treatment was the same in both groups. Two years after treatment 12 of 18 children treated with cyclophosphamide for 12 weeks were still in remission. By contrast, only four of of 18 children treated with cyclophosphamide for eight weeks were still in remission. The cumulative rates of sustained remissions were significantly higher (67% and 22%, respectively) in group A. All relapses were observed within 400 days of stopping cytotoxic treatment. No severe side effects of cyclophosphamide occurred up to two years after treatment had been stopped. We conclude that for children with steroid dependent nephrotic syndrome and steroid toxicity cyclophosphamide treatment should be prolonged to 12 weeks to increase the likelihood of a prolonged remission.




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
A. Meyrier
Nephrotic focal segmental glomerulosclerosis in 2004: an update
Nephrol. Dial. Transplant., October 1, 2004; 19(10): 2437 - 2444.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
Z. Bircan
Steroid-dependent nephrotic syndrome and cyclophosphamide
Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1327 - 1327.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. Donia and M. Sobh
Reply
Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1328 - 1328.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. J. Kemper, E. Kuwertz-Broeking, M. Bulla, D. E. Mueller-Wiefel, and T. J. Neuhaus
Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome
Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1136 - 1141.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. F. Donia, S. H. Gazareen, H. A. Ahmed, F. E. Moustafa, A. A. Shoeib, A. M. Ismail, S. Khamis, and M. A. Sobh
Pulse cyclophosphamide inadequately suppresses reoccurrence of minimal change nephrotic syndrome in corticoid-dependent children
Nephrol. Dial. Transplant., October 1, 2003; 18(10): 2054 - 2058.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
S. Gulati, S. Pokhariyal, R. K. Sharma, R. Elhence, V. Kher, C. M. Pandey, and A. Gupta
Pulse cyclophosphamide therapy in frequently relapsing nephrotic syndrome
Nephrol. Dial. Transplant., October 1, 2001; 16(10): 2013 - 2017.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
G. Smith
Management of childhood nephrotic syndrome
BMJ, February 25, 1995; 310(6978): 530d - 531.
[Full Text]

Home page
 BMJHome page
P D Mason and C D Pusey
Fortnightly Review: Glomerulonephritis: diagnosis and treatment
BMJ, December 10, 1994; 309(6968): 1557 - 1563.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1987 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health